Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-07

FDA Approved: MARAVIROC — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Camber Pharmaceuticals' original application for maraviroc, enabling a generic version of the HIV entry inhibitor.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Maraviroc (maraviroc)

Snippet

ORIG AP for MARAVIROC (MARAVIROC)